Cargando…

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19

Rationale: Coronavirus disease 2019 (COVID-19) can cause disruption of the renin-angiotensin system in the lungs, possibly contributing to pulmonary capillary leakage. Thus, angiotensin receptor blockers (ARBs) may improve respiratory failure. Objective: Assess safety of losartan for use in respirat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bengtson, Charles D., Montgomery, Robert N., Nazir, Usman, Satterwhite, Lewis, Kim, Michael D., Bahr, Nathan C., Castro, Mario, Baumlin, Nathalie, Salathe, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926174/ https://www.ncbi.nlm.nih.gov/pubmed/33681257 http://dx.doi.org/10.3389/fmed.2021.630209

Ejemplares similares

Losartan ameliorates TGF-β1–induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies
por: Kim, Michael D., et al.
Publicado: (2022)

Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
por: Kim, Michael D., et al.
Publicado: (2021)

The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function
por: Bengtson, Charles, et al.
Publicado: (2022)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis
por: Di Stefano, Leon, et al.
Publicado: (2023)

Glutathione Peroxidase-1 Suppresses the Unfolded Protein Response upon Cigarette Smoke Exposure
por: Geraghty, Patrick, et al.
Publicado: (2016)

Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells
por: Baumlin, Nathalie, et al.
Publicado: (2023)

Modulation of Wnt signaling is essential for the differentiation of ciliated epithelial cells in human airways
por: Schmid, Andreas, et al.
Publicado: (2017)

Cigarette smoke exposure reduces leukemia inhibitory factor levels during respiratory syncytial viral infection
por: Poon, Justin, et al.
Publicado: (2019)

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
por: Choi, YoonJung, et al.
Publicado: (2016)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Roflumilast partially reverses smoke-induced mucociliary dysfunction
por: Schmid, Andreas, et al.
Publicado: (2015)

Role of Smad3 and p38 Signalling in Cigarette Smoke-induced CFTR and BK dysfunction in Primary Human Bronchial Airway Epithelial Cells
por: Sailland, Juliette, et al.
Publicado: (2017)

Predictors of Worsening COVID-19 Illness
por: Joob, Beuy, et al.
Publicado: (2021)

Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
por: Geriak, Matthew, et al.
Publicado: (2021)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Protein tyrosine phosphatase 1B negatively regulates S100A9-mediated lung damage during respiratory syncytial virus exacerbations
por: Foronjy, Robert F., et al.
Publicado: (2016)

The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia
por: Zou, Wei, et al.
Publicado: (2021)

Transport of Designed Ankyrin Repeat Proteins through reconstituted human bronchial epithelia and protection against SARS-CoV-2
por: Künzi, Lisa, et al.
Publicado: (2023)

365. Assessing Provider Utilization of COVID-19 Inflammatory Marker Trends in Hospitalized Patients and Implications in Optimizing Value-Based Care During a Pandemic
por: Subramanian, Praveen, et al.
Publicado: (2021)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
por: Brendish, Nathan J, et al.
Publicado: (2017)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction
por: Kim, Michael D., et al.
Publicado: (2022)

A Long Noncoding RNA Antisense to ICAM-1 is Involved in Allergic Asthma Associated Hyperreactive Response of Airway Epithelial Cells
por: Devadoss, Dinesh, et al.
Publicado: (2020)

Respiratory decompensation with proning – when prone positioning can worsen respiratory mechanics
por: Oydanich, Marko, et al.
Publicado: (2022)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

A Case Report of Losartan Induced Angioedema
por: Vedantam, Venkata, et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Losartan-Induced Angioedema: A Case Report
por: Mann, Henry, et al.
Publicado: (2023)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0vv4nfo6ikktpmucq67m1c7b1c